Pharmacokinetic insights into atezolizumab SC: viability of extended dosing intervals beyond the standard regimen

Clinical & Translational Oncology 2026

View at publisher

Authors: Vicente Gimeno‐Ballester, Elena Herranz Bayo, Cristina Trigo-Vicente

DOI: 10.1007/s12094-026-04284-x

Cited by: 0

References: 11

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Pharmaceutical studies and practices Monoclonal and Polyclonal Antibodies Research

References 11